Rackspace Hosting Inc (NYSE:RAX) Stock Upgrade Shares of Rackspace Hosting Inc (NYSE:RAX) were hiked by investment analysts from RBC Capital Markets from a “Sector Perform”…
How RBC Capital Markets Currently Rates Sibanye Gold (NYSE:SBGL) In a recent research report finalized on 1 December, research analysts at RBC Capital Markets initiated…
Telecity (UNKNOWN:TLEIY) Receives a Downgrade RBC Capital Markets has cut the rating for shares of Telecity (UNKNOWN:TLEIY) to a solid “Sector Perform” in a note…
Terraform Power Inc (NASDAQ:TERP) Stock Upgrade In a comprehensive report revealed to clients earlier today, Oppenheimer has raised shares of Terraform Power Inc (NASDAQ:TERP) to…
Why Has FBR Capital Given TG Therapeutics Inc (OTC:TGTX) a $29.00 Price Target In a recent report announced on Tuesday morning, FBR Capital analyst has…
How Stifel Nicolaus Currently Rates Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) Equity analysts at Stifel Nicolaus began coverage on Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) with Buy rating. This…
Why Has Stifel Nicolaus Given Vertex Pharmaceuticals (NASDAQ:VRTX) a $160.00 Price Target Stifel Nicolaus has just issued a Buy rating for Vertex Pharmaceuticals (NASDAQ:VRTX) shares….
Windstream (NASDAQ:WIN) Stock Upgrade In a recent research report released on 1 December, stock research analysts at the Raymond James stock research division raised shares…
Windstream (NASDAQ:WIN) Stock Upgrade It will be interesting to watch today’s trading of shares of Windstream (NASDAQ:WIN) as RBC Capital Markets upgraded the stock from…
How Goldman Sachs Currently Rates Xerox Corporation (NYSE:XRX) The research firm Goldman Sachs has have commenced coverage coverage on Xerox Corporation (NYSE:XRX)’s stock, rating it…
Campbell Soup (NYSE:CPB) Stock Upgrade In a recent research report revealed on 1 December, expert analysts at the equities division of Argus boosted their rating…
Parkway Prop (NYSE:PKY) Stock Upgrade Stock analysts at Stifel’s division of equities hiked the rating on shares of Parkway Prop (NYSE:PKY) from a Hold to…
Why Has Stifel Given Ultragenyx Pharma (NASDAQ:RARE) a $125.0 Price Target Analysts at Stifel commenced coverage coverage on shares of Ultragenyx Pharma (NASDAQ:RARE) in an…
